Providing a sensitive, direct electronic readout without the use of intermediate optics
This innovative Georgia Tech technology overcomes the obstacles of currently available bead-based assays as it can provide a sensitive readout of analyte binding without any intermediate optics. Most bead-based assays in use today depend on expensive optical detection systems, which can limit their widespread use, for example, when needed to detect infectious diseases such as COVID-19. This innovation can be applied to the sensing of any biomarker that can be specifically bound to using a probe, such as proteins, antigens, cells, DNA, RNA, viruses, and bacteria.
The technology uses a bead-based enzyme-linked immunosorbent assay (ELISA) as a first step. This enables analyte binding on antigen-coated microparticles, and the signal is amplified via deposition of silver nanoparticles. Then, the metallized beads flow through a 3D printed micro-aperture, and the change in impedance is captured for each bead as it passes by.
Multiplexing can be achieved by using “impedance-barcoded” beads, where an electronically identifiable property of the bead can be altered that is independent of the electronic signal produced by analyte binding. For example, this could be the shape, porosity, size, conductivity, permittivity, or any combination of the properties.
Georgia Tech Office of Technology Licensing